Multiple studies have suggested that PPARα agonists could become possible promising drugs for retinal ischemia [26,27], and activation of PPARα by fenofibrate has been shown to suppress pathological angiogenesis in the retina in vivo and in vitro [28]. This evidence concerns the gene PPARA and retinal ischemia.